about
HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategiesDendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen.Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adultsFrom mice to humans - murine intelligence for human CD8+ T cell vaccine design.Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.The potential role of fowlpox virus in rational vaccine design.Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus.Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity.
P2860
Q26799624-D19DF93D-8B40-4679-8D41-3B5DCD5283FFQ33725752-C5896C6B-30C9-4FA2-A7A5-76477403DEE8Q33788861-1DDE882C-BEA5-42E3-B7CF-2721B655B22CQ33911986-1D9A9E4A-71A5-4E50-B016-07EFCFEA8171Q35940696-8D7B10CE-024D-4C4E-842F-A5A88D335E06Q36065972-48A871EA-31C3-4149-B33A-5B46DF674AD5Q36377208-24199BA3-18FC-46D6-BA87-003A5B74A04EQ36600376-098CF9D7-B115-4359-B8BE-CFEB20F5EE15Q37857291-C167EB97-ACF9-4B9C-A61A-A8E0DFA3BCF1Q38353693-02004B4C-D550-4577-8616-E89621CC0519Q39547016-258DA19D-01B2-4772-9A33-00284321DCD2Q41526077-EBE7A2CC-C4C1-4CA5-8F4D-960DDB281703
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Viral vectors for inducing CD8+ T cell responses.
@ast
Viral vectors for inducing CD8+ T cell responses.
@en
type
label
Viral vectors for inducing CD8+ T cell responses.
@ast
Viral vectors for inducing CD8+ T cell responses.
@en
prefLabel
Viral vectors for inducing CD8+ T cell responses.
@ast
Viral vectors for inducing CD8+ T cell responses.
@en
P2860
P356
P1476
Viral vectors for inducing CD8+ T cell responses.
@en
P2093
Christopher C Norbury
Mary E Truckenmiller
P2860
P304
P356
10.1517/14712598.4.6.861
P407
P577
2004-06-01T00:00:00Z